Personalised medicine uses an individual’s genetic data to guide treatment of diseases and select proper medication. Its implementation will transform the healthcare sector. But can we really be sure our data is being handled carefully? Should we give our medical history to private companies? How will vast amounts of genomic data change public health?
Speaker:
Herawati Sudoyo is the Chairperson of the Medical Commission of the Indonesian Academy of Sciences. Previously she was the Deputy Director of the Eijkman Institute for Molecular Biology in Jakarta.
Danuta Gawel is a senior bioinformatician at Mavatar AB. Her work focuses on creating a tool that supports clinicians to personalize medication based on digital twins of patients.
